Zoetis' proposed acquisition of Jurox raises preliminary competition concerns* The ACCC has outlined preliminary competition concerns with Zoetis’ proposed acquisition of Jurox in a statement of issues published today. Zoetis and Jurox develop, manufacture, and sell animal health products that detect, prevent, or treat health issues in companion and production animals. “We have concerns that the acquisition will remove one of Zoetis’ closest competitors in the supply of three types of products that are used by farmers to treat or prevent bacterial infections in the teats of cows,” ACCC Deputy Chair Mick Keogh said. “We also have
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.